A patient diagnosed with terminal cancer has been cured and is due to be discharged from hospital on Saturday after undergoing unprecedented genetic treatment by doctors at the University of Sao Paulo, Brazil.
According to information released by the Brazil Agency, Vamberto Castro, 62, underwent a treatment with a method developed in the country that uses altered cells in the laboratory to combat severe lymphoma, while already responding to conventional treatments at the Hospital das Clínicas of the Faculty of Medicine of Ribeirão Preto, in the interior of São Paulo.
The patient was authorized to undergo treatment with the so-called CAR-T cells, still under research.
The doctors in charge of the procedure explained that cell therapy causes the patient's T cells (immune system cell type) to be altered in the laboratory to recognize and attack cancer or tumor cells.
About 20 days after the procedure began, Vamberto Castro's tests showed that the cancer cells disappeared.
CAR-T cells were developed by researchers from the United States of America, where the production of modified cells is already authorized.
. (tagsToTranslate) Jornal de Notícias (t) JN (t) World (t) Brazil (t) cancer (t) health